Total Payments
$1,866
2024 Payments
$159.52
Companies
13
Transactions
18
Medicare Patients
2,944
Medicare Billing
$342,258
Payment Breakdown by Category
Consulting$1,000 (53.6%)
Food & Beverage$866.41 (46.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,000 | 1 | 53.6% |
| Food and Beverage | $866.41 | 17 | 46.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sebela Pharmaceuticals Inc. | $1,000 | 1 | $0 (2017) |
| Medtronic, Inc. | $383.56 | 2 | $0 (2022) |
| REVANCE THERAPEUTICS, INC. | $138.02 | 1 | $0 (2024) |
| ABBVIE INC. | $124.30 | 1 | $0 (2022) |
| Cook Medical LLC | $59.32 | 3 | $0 (2024) |
| Novo Nordisk Inc | $30.79 | 2 | $0 (2021) |
| Takeda Pharmaceuticals America, Inc. | $26.57 | 2 | $0 (2017) |
| Olympus America Inc. | $25.57 | 1 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20.24 | 1 | $0 (2018) |
| UCB, Inc. | $17.74 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $159.52 | 3 | REVANCE THERAPEUTICS, INC. ($138.02) |
| 2023 | $25.57 | 1 | Olympus America Inc. ($25.57) |
| 2022 | $507.86 | 3 | Medtronic, Inc. ($383.56) |
| 2021 | $30.79 | 2 | Novo Nordisk Inc ($30.79) |
| 2019 | $37.82 | 1 | Cook Medical LLC ($37.82) |
| 2018 | $47.17 | 3 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($20.24) |
| 2017 | $1,058 | 5 | Sebela Pharmaceuticals Inc. ($1,000) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | Cook Medical LLC | HEMOSPRAY (Device) | Food and Beverage | Cash or cash equivalent | $12.66 | General |
| Category: Endoscopy | ||||||
| 03/21/2024 | Cook Medical LLC | HEMOSPRAY (Device) | Food and Beverage | Cash or cash equivalent | $8.84 | General |
| Category: Endoscopy | ||||||
| 03/06/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $138.02 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/01/2023 | Olympus America Inc. | EndoClot PHS (Device) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: Endotherapy | ||||||
| 06/23/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.30 | General |
| Category: IMMUNOLOGY | ||||||
| 03/01/2022 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $238.10 | General |
| Category: Gastrointestinal AI | ||||||
| 02/22/2022 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $145.46 | General |
| Category: Gastrointestinal AI | ||||||
| 02/25/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Obesity | ||||||
| 01/13/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Obesity | ||||||
| 10/25/2019 | Cook Medical LLC | Cook Medical Zilver PTX (Device) | Food and Beverage | Cash or cash equivalent | $37.82 | General |
| Category: Peripheral Intervention | ||||||
| 09/18/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2018 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/15/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Gastroenterology | ||||||
| 10/05/2017 | Sebela Pharmaceuticals Inc. | MOTOFEN (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 05/02/2017 | Takeda Pharmaceuticals America, Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Lower GI | ||||||
| 01/31/2017 | Janssen Biotech, Inc. | STELARA (Biological), REMICADE, SIMPONI | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Immunology | ||||||
| 01/11/2017 | Takeda Pharmaceuticals America, Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Lower GI | ||||||
| 01/06/2017 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 814 | 13,360 | $1.2M | $105,101 |
| 2022 | 14 | 680 | 806 | $915,269 | $72,352 |
| 2021 | 11 | 796 | 825 | $1.1M | $92,897 |
| 2020 | 12 | 654 | 686 | $854,839 | $71,909 |
Total Patients
2,944
Total Services
15,677
Medicare Billing
$342,258
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 147 | 147 | $317,520 | $28,827 | 9.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 18 | 1,200 | $91,200 | $21,946 | 24.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 131 | 132 | $227,304 | $11,672 | 5.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 123 | 126 | $189,000 | $7,424 | 3.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 105 | $23,100 | $6,479 | 28.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 35 | 35 | $56,175 | $5,868 | 10.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 32 | 32 | $51,360 | $5,462 | 10.6% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 17 | 11,220 | $33,660 | $4,397 | 13.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 30 | 30 | $130,860 | $2,781 | 2.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 19 | 20 | $32,100 | $2,382 | 7.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 28 | 48 | $10,800 | $2,008 | 18.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 28 | 29 | $6,366 | $1,949 | 30.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $6,688 | $1,603 | 24.0% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 37 | 39 | $7,371 | $1,016 | 13.8% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 23 | 115 | $20,975 | $667.57 | 3.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 60 | $4,500 | $619.68 | 13.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 111 | 112 | $237,104 | $20,847 | 8.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 106 | 106 | $178,928 | $10,901 | 6.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 47 | 47 | $73,931 | $8,399 | 11.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 126 | $27,090 | $7,519 | 27.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 110 | 112 | $164,640 | $6,992 | 4.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 30 | 59 | $12,980 | $2,775 | 21.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 36 | 42 | $8,974 | $2,611 | 29.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 32 | 32 | $9,536 | $2,582 | 27.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 25 | 27 | $115,452 | $2,581 | 2.2% |
About Dr. Nicholas Anthony, MD
Dr. Nicholas Anthony, MD is a Internal Medicine healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1265607907.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Anthony, MD has received a total of $1,866 in payments from pharmaceutical and medical device companies, with $159.52 received in 2024. These payments were reported across 18 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($1,000).
As a Medicare-enrolled provider, Anthony has provided services to 2,944 Medicare beneficiaries, totaling 15,677 services with total Medicare billing of $342,258. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Charlotte, NC
- Active Since 04/24/2008
- Last Updated 07/15/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1265607907
Products in Payments
- MOTOFEN (Drug) $1,000
- GI GENIUS (Device) $383.56
- DAXXIFY (Drug) $138.02
- RINVOQ (Biological) $124.30
- Cook Medical Zilver PTX (Device) $37.82
- Saxenda (Drug) $30.79
- Entyvio (Biological) $26.57
- EndoClot PHS (Device) $25.57
- HEMOSPRAY (Device) $21.50
- XIFAXAN (Drug) $20.24
- Cimzia (Drug) $17.74
- Trulance (Drug) $15.23
- STELARA (Biological) $13.37
- CLENPIQ (Drug) $11.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charlotte
Ryan Jacobs, Md, MD
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Saad Usmani, Md, MD
Internal Medicine — Payments: $747,509
Internal Medicine $747,509
Michael Rinaldi, Md, MD
Internal Medicine — Payments: $646,787
Internal Medicine $646,787
Dr. Richard Browne, M.d, M.D
Internal Medicine — Payments: $638,169
Internal Medicine $638,169
Sanjeev Gulati, Md, MD
Internal Medicine — Payments: $598,822
Internal Medicine $598,822
Dr. Raymond Thertulien, M.d, M.D
Internal Medicine — Payments: $584,601
Internal Medicine $584,601